PRISMA

2.1 Classification of the substance or mixture

unconscious person. If unconscious, place in recovery position and seek medical advice.

Product definition

Mixture. Eye contact: Check for and remove any contact lenses. Immediately

2.2 Label elements

by trained personnel.

Signal word

No signal word. Skin contact: Remove contaminated clothing and shoes. Wash skin

Hazard statements

No known significant effects or critical hazards. thoroughly with soap and water or use recognised skin

Precautionary statements

cleanser. Do NOT use solvents or thinners. Ingestion: General: If swallowed, seek medical advice immediately and show the Keep out of reach of children. container or label. Keep person warm and at rest.

Prevention

Use personal protective equipment as required. Do NOT induce vomiting.

Response

IF ON SKIN: Wash with plenty of soap and water. Protection of first-aiders: No action shall be taken involving any personal risk IF IN EYES: Rinse cautiously withwater for several minutes. or without suitable training. Remove contact lenses, if present and easy to do. 4.2 Most important symptoms and effects, both acute and delayed Continue rinsing. There are no data available on the mixture itself. See Sections 2 and 3 for details.

Storage

Not applicable. Repeated or prolonged contact with the mixture may cause removal of natural fat from the skin, resulting in nonallergic contact dermatitis and absorption through the

Disposal

Dispose of contents/container to skin. If splashed in the eyes, the liquid may cause irritation and reversible damage. recognised waste collection point. This takes into account, where known, delayed and immediate effects and also chronic effects of components from short-term and long-term expo-

Supplemental label elements

sure by oral, inhalation and dermal routes of exposure and eye contact. elements:

Contains

Reaction mass of 5-chloro-2-methyl- methyl-4-isothiazolin-3-one [EC no.247-500-7] 4.3 Indication of any immediate medical attention and special treat- and 2-methyl-2H-isothiazol-3-one [EC no. 220-239-6] ment needed (3:1). May produce an allergic reaction. Safety data sheet available on request. Notes to physician: Treat symptomatically. Contact poison treatment specialist immediately if large quantities have

Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles

Specific treatments: No specific treatment. See toxicological information (Section 11) Not applicable.